Intrinsic Value of S&P & Nasdaq Contact Us

Apogee Therapeutics, Inc. APGE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$105.63
+19.4%

Stock Statistics — APGE

Apogee Therapeutics, Inc. (APGE) has a market capitalization of $4.95B and trades at $88.47. The 52-week range is 26.2-85.94.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -21, Earnings Per Share (EPS) of $-4.22.

The stock has a beta of 1.03, operates in the Healthcare sector.

Trading Data
Current Price$88.47
52-Week Range26.2-85.94
Volume555.07K
Avg Volume (30D)1.04M
Market Cap$4.95B
Beta (1Y)1.03
Company
IPO Date2023-07-14
Employees196
CEOMichael Thomas Henderson
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS03770N1019
CUSIP432705309
Income (Latest Year)
Gross Profit$-1.42M
EBITDA$-284.18M
Operating Income$-285.6M
Net Income$-255.84M
EPS$-4.22
EPS Diluted$-4.22
Shares Outstanding$60.69M
Balance Sheet (Latest Year)
Total Assets$937.13M
Current Assets$741.36M
Cash & ST Investments$730.19M
Total Liabilities$33.25M
Total Debt$8.85M
Net Debt$-122.7M
Total Equity$903.88M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-21
P/B Ratio5.48
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message